BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10741748)

  • 1. Clinical significance of matrix metalloproteinase-7 expression in esophageal carcinoma.
    Yamashita K; Mori M; Shiraishi T; Shibuta K; Sugimachi K
    Clin Cancer Res; 2000 Mar; 6(3):1169-74. PubMed ID: 10741748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical significance of MMP-1 expression in oesophageal carcinoma.
    Yamashita K; Mori M; Kataoka A; Inoue H; Sugimachi K
    Br J Cancer; 2001 Jan; 84(2):276-82. PubMed ID: 11161388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of secreted protein acidic and rich in cystein in esophageal carcinoma and its relation to carcinoma progression.
    Yamashita K; Upadhay S; Mimori K; Inoue H; Mori M
    Cancer; 2003 May; 97(10):2412-9. PubMed ID: 12733139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of matrilysin-2 (MMP-26) expression with tumor progression and activation of MMP-9 in esophageal squamous cell carcinoma.
    Yamamoto H; Vinitketkumnuen A; Adachi Y; Taniguchi H; Hirata T; Miyamoto N; Nosho K; Imsumran A; Fujita M; Hosokawa M; Hinoda Y; Imai K
    Carcinogenesis; 2004 Dec; 25(12):2353-60. PubMed ID: 15333466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of expression of membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 in human head and neck squamous cell carcinoma.
    Imanishi Y; Fujii M; Tokumaru Y; Tomita T; Kanke M; Kanzaki J; Kameyama K; Otani Y; Sato H
    Hum Pathol; 2000 Aug; 31(8):895-904. PubMed ID: 10987249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue inhibitor of metalloproteinase 1 is an independent predictor of prognosis in patients with nonsmall cell lung carcinoma who undergo resection with curative intent.
    Gouyer V; Conti M; Devos P; Zerimech F; Copin MC; Créme E; Wurtz A; Porte H; Huet G
    Cancer; 2005 Apr; 103(8):1676-84. PubMed ID: 15754326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of lysyl oxidase is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.
    Sakai M; Kato H; Sano A; Tanaka N; Inose T; Kimura H; Sohda M; Nakajima M; Kuwano H
    Ann Surg Oncol; 2009 Sep; 16(9):2494-501. PubMed ID: 19526206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of matrix metalloproteinase-7 on cancer cells and tissue endothelial cells in renal cell carcinoma: prognostic implications and clinical significance for invasion and metastasis.
    Miyata Y; Iwata T; Ohba K; Kanda S; Nishikido M; Kanetake H
    Clin Cancer Res; 2006 Dec; 12(23):6998-7003. PubMed ID: 17145820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix metalloproteinase-7 expression in colorectal cancer liver metastases: evidence for involvement of MMP-7 activation in human cancer metastases.
    Zeng ZS; Shu WP; Cohen AM; Guillem JG
    Clin Cancer Res; 2002 Jan; 8(1):144-8. PubMed ID: 11801551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix metalloproteinase-7 expression and biologic aggressiveness of cholangiocellular carcinoma.
    Miwa S; Miyagawa S; Soeda J; Kawasaki S
    Cancer; 2002 Jan; 94(2):428-34. PubMed ID: 11900228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of ornithine decarboxylase messenger RNA in human esophageal carcinoma.
    Mafune K; Tanaka Y; Mimori K; Mori M; Takubo K; Makuuchi M
    Clin Cancer Res; 1999 Dec; 5(12):4073-8. PubMed ID: 10632342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activin A enhances MMP-7 activity via the transcription factor AP-1 in an esophageal squamous cell carcinoma cell line.
    Yoshinaga K; Mimori K; Inoue H; Kamohara Y; Yamashita K; Tanaka F; Mori M
    Int J Oncol; 2008 Sep; 33(3):453-9. PubMed ID: 18695873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of matrix metalloproteinase-7 and Ets-1 gene expression in patients with lung cancer.
    Sasaki H; Yukiue H; Moiriyama S; Kobayashi Y; Nakashima Y; Kaji M; Kiriyama M; Fukai I; Yamakawa Y; Fujii Y
    J Surg Res; 2001 Dec; 101(2):242-7. PubMed ID: 11735282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An inducible short-hairpin RNA vector against osteopontin reduces metastatic potential of human esophageal squamous cell carcinoma in vitro and in vivo.
    Ito T; Hashimoto Y; Tanaka E; Kan T; Tsunoda S; Sato F; Higashiyama M; Okumura T; Shimada Y
    Clin Cancer Res; 2006 Feb; 12(4):1308-16. PubMed ID: 16489088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between E-cadherin, matrix metalloproteinase-7 gene expression and clinicopathological features in gastric carcinoma.
    Lee KH; Shin SJ; Kim KO; Kim MK; Hyun MS; Kim TN; Jang BI; Kim SW; Song SK; Kim HS; Bae SH; Ryoo HM
    Oncol Rep; 2006 Oct; 16(4):823-30. PubMed ID: 16969501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High MMP-1 mRNA expression is a risk factor for disease-free and overall survivals in patients with invasive breast carcinoma.
    Cheng S; Tada M; Hida Y; Asano T; Kuramae T; Takemoto N; Hamada J; Miyamoto M; Hirano S; Kondo S; Moriuchi T
    J Surg Res; 2008 May; 146(1):104-9. PubMed ID: 17663001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of matrix metalloproteinases-9,2,7,and tissue inhibitor of metalloproteinases-1,2,3 mRNA in ovarian tumors and their clinical significance].
    Hu XX; Li L; Li DR; Zhang W; Cheng XQ; Zhang JQ; Tang BJ
    Ai Zheng; 2004 Oct; 23(10):1194-8. PubMed ID: 15473934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in the hepatocellular carcinomas].
    Wei QY; Wu YQ; Fan SQ
    Hunan Yi Ke Da Xue Xue Bao; 2003 Jun; 28(3):212-6. PubMed ID: 14653069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relationship of matrilysin with invasion, metastasis, and prognosis in laryngeal cancer].
    Sun YN; Li Y; Xie MQ; Jin DJ; Li P
    Ai Zheng; 2004 May; 23(5):589-92. PubMed ID: 15142461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder.
    Slaton JW; Karashima T; Perrotte P; Inoue K; Kim SJ; Izawa J; Kedar D; McConkey DJ; Millikan R; Sweeney P; Yoshikawa C; Shuin T; Dinney CP
    Clin Cancer Res; 2001 Sep; 7(9):2840-53. PubMed ID: 11555602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.